# Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)

> **NCT00972842** · PHASE1,PHASE2 · TERMINATED · sponsor: **Arbeitsgemeinschaft medikamentoese Tumortherapie** · enrollment: 20 (estimated)

## Conditions studied

- Peripheral T-Cell Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Vorinostat, Lenalidomide

## Key facts

- **NCT ID:** NCT00972842
- **Lead sponsor:** Arbeitsgemeinschaft medikamentoese Tumortherapie
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** slow recruitment
- **Last updated:** 2013-12-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00972842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00972842, "Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00972842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*